• 1
    National Collaborating Centre for Chronic Conditions (UK), Centre for Clinical Practice at NICE (UK). Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London: National Institute for Health and Clinical Excellence (UK); 2011.
  • 2
    Brouqui P, Delaigue S, Parola P, Drancourt M. Interferon-γ release assay: use and misuse. Clin Microbiol Infect 2012; 18: 10531054. doi: 10.1111/1469-0691.12025.
  • 3
    Health Protection Agency Position Statement on the use of Interferon Gamma Release Assay (IGRA) tests for tuberculosis (TB) (Draft Interim HPA Guidance), Oct 2007.
  • 4
    Pozniak AL, Coyne KM, Miller RF et al. British HIV Association guidelines for the treatment of TB/HIV coinfection 2011. HIV Med 2011; 12: 517524.
  • 5
    Sester M, Sotgiu G, Lange C et al. Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J 2011; 37: 100111.
  • 6
    Dai Y, Feng Y, Xu R, Xu W, Lu W, Wang J. Evaluation of interferon-γ release assays for the diagnosis of tuberculosis: an updated meta-analysis. Eur J Clin Microbiol Infect Dis 2012; 31: 31273137.
  • 7
    Chen J, Zhang R, Wang J et al. Interferon-γ release assays for the diagnosis of active tuberculosis in HIV-infected patients: a systematic review and meta-analysis. PLoS ONE 2011; 6: e26827.
  • 8
    Winqvist N, Björkman P, Norén A, Miörner H. Use of a T cell interferon γ release assay in the investigation for suspected active tuberculosis in a low prevalence area. BMC Infect Dis 2009; 9: 105.
  • 9
    Dosanjh DP, Hinks TS, Innes JA et al. Improved diagnostic evaluation of suspected tuberculosis in routine practice. Ann Intern Med 2008; 148: 325336.
  • 10
    QuantiFERON-TB Gold (In-Tube Method) Package Insert. Australia: Cellestis.
  • 11
    Feng Y, Diao N, Shao L et al. Interferon-γ release assay performance in pulmonary and extrapulmonary tuberculosis. PLoS ONE 2012; 7: e32652.
  • 12
    Detjen AK, Keil T, Roll S et al. Interferon-γ release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis 2007; 45: 322328.
  • 13
    Vesenbeckh SM, Schönfeld N, Mauch H et al. The use of interferon γ release assays in the diagnosis of active tuberculosis. Tuberc Res Treat 2012; 2012: 768723.
  • 14
    Metcalfe JZ, Everett CK, Steingart KR et al. Interferon-γ release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis. J Infect Dis 2011; 4: S1120S1129.
  • 15
    Ling DI, Pai M, Davids V et al. Are interferon-γ release assays useful for diagnosing active tuberculosis in a high-burden setting? Eur Respir J 2011; 38: 649656.